Alaunos Therapeutics: Keep An Eye On Upcoming TCR-T Solid Tumor Study Data (NASDAQ:TCRT)

Alaunos has undergone a name change and a staff and management overhaul over the past 12 months.

Related Keywords

China ,Boston ,Massachusetts ,United States ,Houston ,Texas ,Takara Bio ,Lyell Immunopharma ,James Huang ,Kleiner Perkins Caulfield ,Bristol Myers Squibb ,Jaime Vieser ,Iovance Biotherapeutics ,Robert Postma ,Gilead Sciences ,National Cancer Institute ,Lab Experiment ,Zai Lab ,Md Anderson Cancer Centre ,Md Anderson Cancer Center ,International Cancer Immunotherapy Conference ,Zai Lab Limited ,Life Sciences ,Alaunos Therapeutics ,Watermill Asset Management ,Sleeping Beauty ,Holder Weis ,Chair Scott Tarriff ,Managing Partner ,Legend Biotech ,Multiple Myeloma ,Cancer Center ,Myers Squibb ,Drew Deninger ,New England Journal ,Investigational New Drug ,Adaptimmune Therapeutics ,Affinit Therapeutics ,Nurix Therapeutics ,Neogene Therapeutics ,Tactiva Therapeutics ,T Knife Therapeutics ,Tmunity Therapeutics ,Turnstone Biologics ,Data Will Reveal ,Watermill Asset ,